Company / Return on Assets (ROA)
Processa Pharmaceuticals, Inc. Return on Assets (ROA) History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-132.6%
FY2022
5-year range
-103621.5% / -54.5%
FY2018-FY2022
Trend
-143.4%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -103621.5% to -132.6% over the past 6 years.
Based on SEC 10-K filings.
-132.6% in FY2022.
Improved from -103621.5% to -132.6% over the past 6 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2022, return on assets (roa) decreased 143.4% year-over-year.
- Peak return on assets (roa) was recorded in FY2021.
- Lowest return on assets (roa) in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2022 | -132.6% | -143.4% |
| FY2021 | -54.5% | +99.9% |
| FY2016 | -103621.5% | -2288.3% |
| FY2015 | -4338.8% | -3494.1% |
| FY2014 | -120.7% | -45.3% |
| FY2013 | -83.1% | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026